Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS

Neurobiology of Disease
Susan E BrowneM Flint Beal

Abstract

Multiple cell death pathways are implicated in the etiology of amyotrophic lateral sclerosis (ALS), but the cause of the characteristic motor neuron degeneration remains unknown. To determine whether CNS metabolic defects are critical for ALS pathogenesis, we examined the temporal evolution of energetic defects in the G93A SOD1 mouse model of familial ALS. [14C]-2-deoxyglucose in vivo autoradiography in G93A mice showed that glucose utilization is impaired in components of the corticospinal and bulbospinal motor tracts prior to either pathologic or bioenergetic changes in the spinal cord. This was accompanied by significant depletions in cortical ATP content in presymptomatic mice, which was partially ameliorated by creatine administration. Findings suggest that bioenergetic defects are involved in the initial stages of mSOD1-induced toxicity in G93A mice and imply that the selective dysfunction and degeneration of spinal cord motor neurons in this model may be secondary to dysfunction within cerebral motor pathways.

References

Apr 1, 1992·Neurology·R L Albin, J T Greenamyre
Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoG Saccomanno
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J D RothsteinR W Kuncl
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·R T MatthewsM F Beal
Nov 22, 2000·Brain Research. Brain Research Reviews·A Ames
Mar 27, 2001·Muscle & Nerve·A Eisen, M Weber
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·David S HowlandJeffrey D Rothstein
Apr 30, 2002·Free Radical Biology & Medicine·Silke WendtOle A Andreassen
May 22, 2002·Journal of Neurology·G BensimonUNKNOWN Riluzole/ALS Study Group II
Jun 7, 2002·The Journal of Biological Chemistry·Marina MattiazziGiovanni Manfredi
Jun 22, 2002·Brain : a Journal of Neurology·Fiona M MenziesPamela J Shaw
Jun 5, 2003·Pharmacology & Therapeutics·Michael J Strong
Apr 2, 2004·Neurobiology of Disease·Peter KlivenyiM Flint Beal
Jul 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Luc DupuisJean-Philippe Loeffler
Jan 7, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ilias G KirkinezosCarlos T Moraes
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Chetan VijayvergiyaGiovanni Manfredi

❮ Previous
Next ❯

Citations

Mar 3, 2009·Amino Acids·Bruno GualanoAntonio Herbert Lancha Junior
Nov 11, 2011·Journal of Bioenergetics and Biomembranes·Liesbeth Faes, Geert Callewaert
Jun 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·James C DodgeLamya S Shihabuddin
May 13, 2008·Brain : a Journal of Neurology·Steve VucicMatthew C Kiernan
Oct 24, 2008·PloS One·Yasuhiro WatanabeKenji Nakashima
Mar 7, 2014·PloS One·Nirma D PereraBradley J Turner
Jan 21, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·M A LimR G Kalb
Jun 15, 2014·Trends in Neurosciences·Steve VucicMatthew C Kiernan
Jan 12, 2013·Cell Death and Differentiation·A T BehanJ H M Prehn
Dec 3, 2009·The Journal of Cell Biology·Hristelina IlievaDon W Cleveland
May 23, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Renaid B KimCassie S Mitchell
Dec 24, 2008·Journal of Neuropathology and Experimental Neurology·Roman M KassaMarina Bentivoglio
Nov 26, 2015·Neuroscience and Biobehavioral Reviews·Alida Spalloni, Patrizia Longone
Jun 12, 2014·Journal of Neuropathology and Experimental Neurology·Mariona JovéReinald Pamplona
Oct 18, 2008·Experimental Neurology·Diego MinciacchiMarina Bentivoglio
Mar 1, 2008·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Andrew Eisen
May 27, 2008·Brain Research Bulletin·Robert H AndresHans Rudolf Widmer
Aug 9, 2015·Progress in Neurobiology·Renzo Mancuso, Xavier Navarro
Sep 28, 2007·The European Journal of Neuroscience·Eva HedlundOle Isacson
Jul 24, 2015·Neurochemical Research·Nirma D Perera, Bradley J Turner
May 9, 2007·Bioscience Reports·Lucia PetrozziMichelangelo Mancuso
Feb 27, 2014·Biochimica Et Biophysica Acta·Wenzhi TanDavide Trotti
Mar 19, 2013·Neuron·Fernando BartolomeHelene Plun-Favreau
Oct 4, 2006·Neuron·Séverine BoilléeDon W Cleveland
Sep 18, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Parvathi MenonSteve Vucic
Dec 25, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Steve VucicMatthew C Kiernan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.